|
|
|
Insider
Information: |
Mirviss Jeffrey B. |
Relationship: |
EVP&Pres, Periph Inter... |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
58,098 |
|
Indirect Shares
|
25,000 |
|
|
Direct
Value |
$4,184,799 |
|
|
Indirect Value
|
$1,800,750 |
|
|
Total
Shares |
83,098 |
|
|
Total
Value |
$5,985,549 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP&Pres, Periph Inter... |
2024-03-18 |
58,098 |
2020-09-03 |
25,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
222 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
165 |
115,622 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-09-01 |
4 |
OE |
$6.31 |
$378,600 |
D/D |
60,000 |
175,622 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-09-01 |
4 |
AS |
$40.93 |
$2,456,028 |
D/D |
(60,000) |
115,622 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-09-03 |
4 |
AS |
$42.31 |
$386,671 |
D/D |
(9,139) |
106,483 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-01 |
4 |
AS |
$33.53 |
$1,562,106 |
D/D |
(46,584) |
131,483 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-01 |
4 |
OE |
$7.16 |
$333,541 |
D/D |
46,584 |
178,067 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
132,132 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-03 |
4 |
D |
$33.81 |
$10,008 |
D/D |
(296) |
131,836 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
50 |
131,786 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
131,636 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-01-01 |
4 |
D |
$35.95 |
$138,731 |
D/D |
(3,859) |
139,744 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,967 |
143,603 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-01-05 |
4 |
AS |
$35.31 |
$286,333 |
D/D |
(8,108) |
131,636 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-10 |
4 |
D |
$38.85 |
$94,134 |
D/D |
(2,423) |
137,087 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,917 |
139,510 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-12 |
4 |
AS |
$38.75 |
$212,893 |
D/D |
(5,494) |
131,593 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,030 |
133,623 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-15 |
4 |
D |
$38.39 |
$23,879 |
D/D |
(622) |
133,001 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,816 |
135,817 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-18 |
4 |
D |
$37.52 |
$32,342 |
D/D |
(862) |
134,955 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
137,759 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-21 |
4 |
D |
$38.03 |
$36,851 |
D/D |
(969) |
136,790 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,318 |
139,108 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-22 |
4 |
D |
$39.20 |
$41,474 |
D/D |
(1,058) |
138,050 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-02-28 |
4 |
D |
$38.78 |
$36,027 |
D/D |
(929) |
139,158 |
0 |
- |
|
222 Records found
|
|
Page 1 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|